[go: up one dir, main page]

MX2011011342A - Compuestos de vinil indazolilo. - Google Patents

Compuestos de vinil indazolilo.

Info

Publication number
MX2011011342A
MX2011011342A MX2011011342A MX2011011342A MX2011011342A MX 2011011342 A MX2011011342 A MX 2011011342A MX 2011011342 A MX2011011342 A MX 2011011342A MX 2011011342 A MX2011011342 A MX 2011011342A MX 2011011342 A MX2011011342 A MX 2011011342A
Authority
MX
Mexico
Prior art keywords
vinyl
compounds
indazolyl compounds
vinyl indazolyl
indazoiyl
Prior art date
Application number
MX2011011342A
Other languages
English (en)
Inventor
Daohong Chen
Hong-Yu Li
Genshi Zhao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2011011342A publication Critical patent/MX2011011342A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención proporciona compuestos de vinil imidazolilo útiles en el tratamiento de cáncer.
MX2011011342A 2009-05-07 2010-05-04 Compuestos de vinil indazolilo. MX2011011342A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17629009P 2009-05-07 2009-05-07
US30141610P 2010-02-04 2010-02-04
PCT/US2010/033487 WO2010129509A1 (en) 2009-05-07 2010-05-04 Vinyl indazolyl compounds

Publications (1)

Publication Number Publication Date
MX2011011342A true MX2011011342A (es) 2011-11-18

Family

ID=42238704

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011342A MX2011011342A (es) 2009-05-07 2010-05-04 Compuestos de vinil indazolilo.

Country Status (35)

Country Link
US (1) US8268869B2 (es)
EP (1) EP2427449B1 (es)
JP (1) JP5555314B2 (es)
KR (1) KR101373910B1 (es)
CN (1) CN102421769B (es)
AR (1) AR078411A1 (es)
AU (1) AU2010246114B2 (es)
BR (1) BRPI1013748A2 (es)
CA (1) CA2760535C (es)
CL (1) CL2011002781A1 (es)
CO (1) CO6450624A2 (es)
CR (1) CR20110580A (es)
DK (1) DK2427449T3 (es)
EA (1) EA018149B1 (es)
EC (1) ECSP11011441A (es)
ES (1) ES2408117T3 (es)
HK (1) HK1163665A1 (es)
HN (1) HN2011002809A (es)
HR (1) HRP20130323T1 (es)
IL (1) IL216004A (es)
JO (1) JO2860B1 (es)
MA (1) MA33244B1 (es)
ME (1) ME01462B (es)
MX (1) MX2011011342A (es)
MY (1) MY160390A (es)
NZ (1) NZ595553A (es)
PE (2) PE20160124A1 (es)
PL (1) PL2427449T3 (es)
PT (1) PT2427449E (es)
RS (1) RS52795B (es)
SG (1) SG175909A1 (es)
SI (1) SI2427449T1 (es)
TW (1) TWI382982B (es)
UA (1) UA104756C2 (es)
WO (1) WO2010129509A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3062B1 (ar) * 2010-10-05 2017-03-15 Lilly Co Eli R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
KR20220017512A (ko) 2012-03-08 2022-02-11 아스테라스 세이야쿠 가부시키가이샤 신규 fgfr3 융합체
LT3176170T (lt) 2012-06-13 2019-04-25 Incyte Holdings Corporation Pakeisti tricikliniai junginiai, kaip fgfr inhibitoriai
US20150203589A1 (en) 2012-07-24 2015-07-23 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EP2968551B1 (en) 2013-03-15 2021-05-05 The Trustees of Columbia University in the City of New York Fusion proteins and methods thereof
AU2014253798C1 (en) 2013-04-19 2019-02-07 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
CN103819396B (zh) * 2014-02-26 2016-06-15 四川大学 一种手性的1-（3,5-二氯吡啶-4-基）-乙醇的合成方法
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3925979A3 (en) 2014-12-23 2022-03-23 The Trustees of Columbia University in the City of New York Fgfr-tacc fusion proteins and methods thereof
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
ES2751669T3 (es) 2015-02-20 2020-04-01 Incyte Corp Heterociclos bicíclicos como inhibidores FGFR
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
CN105906621A (zh) * 2015-04-06 2016-08-31 四川百利药业有限责任公司 用作fgfr抑制剂的乙醇类化合物
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
EP3333157B1 (en) * 2015-08-07 2020-12-23 Harbin Zhenbao Pharmaceutical Co., Ltd. Vinyl compounds as fgfr and vegfr inhibitors
WO2017028816A1 (zh) 2015-08-20 2017-02-23 浙江海正药业股份有限公司 吲哚类衍生物及其制备方法和其在医药上的用途
CN107459519A (zh) 2016-06-06 2017-12-12 上海艾力斯医药科技有限公司 稠合嘧啶哌啶环衍生物及其制备方法和应用
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
MA52493A (fr) 2018-05-04 2021-03-10 Incyte Corp Sels d'un inhibiteur de fgfr
JP2021523121A (ja) 2018-05-04 2021-09-02 インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ Ｆｇｆｒ阻害剤の固体形態及びその調製プロセス
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
BR112022007163A2 (pt) 2019-10-14 2022-08-23 Incyte Corp Heterociclos bicíclicos como inibidores de fgfr
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
EP4056558A4 (en) * 2019-11-06 2023-12-27 Jinan University INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USES THEREOF
JP2023505257A (ja) 2019-12-04 2023-02-08 インサイト・コーポレイション Ｆｇｆｒ阻害剤の誘導体
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US20230115528A1 (en) * 2019-12-30 2023-04-13 Tyra Biosciences, Inc. Indazole compounds
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
EP4186894B1 (en) 2020-08-11 2024-12-04 Henan Medinno Pharmaceutical Technology Co., Ltd. Fgfr inhibitor compound and use thereof
EP4323405A1 (en) 2021-04-12 2024-02-21 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
EP4352059A1 (en) 2021-06-09 2024-04-17 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN116554148B (zh) * 2022-12-13 2025-01-28 药康众拓(北京)医药科技有限公司 一种乙烯基吲唑类氘代fgfr抑制剂药物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
KR100765841B1 (ko) 2000-09-11 2007-10-10 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 티로신 키나제 억제제로서의 퀴놀리논 유도체
JP4383870B2 (ja) * 2001-10-17 2009-12-16 協和発酵キリン株式会社 線維芽細胞増殖因子受容体自己リン酸化を阻害するキノリン誘導体およびキナゾリン誘導体並びにそれらを含有する医薬組成物
CN1656079A (zh) * 2002-05-31 2005-08-17 卫材株式会社 吡唑化合物和含有该化合物的药物组合物
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
CA2568050A1 (en) 2004-05-26 2005-12-08 Pfizer, Inc. Indazole and indolone derivatives and their use as pharmaceuticals
WO2007058626A1 (en) 2005-11-16 2007-05-24 S*Bio Pte Ltd Indazole compounds
WO2007067537A1 (en) * 2005-12-07 2007-06-14 Osi Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
PT2120932E (pt) 2006-12-20 2014-10-10 Nerviano Medical Sciences Srl Derivados de indazol como inibidores da quinase para tratamento do cancro
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
CA2694860A1 (en) 2007-06-05 2008-12-18 Schering Corporation Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
DE102007028521A1 (de) 2007-06-21 2008-12-24 Merck Patent Gmbh Indazolamidderivate
EP2265270A1 (en) * 2008-02-04 2010-12-29 OSI Pharmaceuticals, Inc. 2-aminopyridine kinase inhibitors

Also Published As

Publication number Publication date
JO2860B1 (en) 2015-03-15
PT2427449E (pt) 2013-05-06
CA2760535A1 (en) 2010-11-11
EP2427449A1 (en) 2012-03-14
ME01462B (me) 2014-04-20
SG175909A1 (en) 2011-12-29
ES2408117T3 (es) 2013-06-18
CO6450624A2 (es) 2012-05-31
MY160390A (en) 2017-03-15
CN102421769A (zh) 2012-04-18
HN2011002809A (es) 2013-07-22
ECSP11011441A (es) 2011-12-30
NZ595553A (en) 2013-05-31
HK1163665A1 (en) 2012-09-14
UA104756C2 (uk) 2014-03-11
IL216004A0 (en) 2012-01-31
TW201105652A (en) 2011-02-16
RS52795B (en) 2013-10-31
WO2010129509A1 (en) 2010-11-11
CR20110580A (es) 2012-01-06
AU2010246114A1 (en) 2011-11-03
EA018149B1 (ru) 2013-05-30
KR101373910B1 (ko) 2014-03-12
CA2760535C (en) 2014-01-14
JP5555314B2 (ja) 2014-07-23
US8268869B2 (en) 2012-09-18
PL2427449T3 (pl) 2013-08-30
CN102421769B (zh) 2014-04-02
PE20160124A1 (es) 2016-02-24
SI2427449T1 (sl) 2013-05-31
HRP20130323T1 (en) 2013-05-31
JP2012526126A (ja) 2012-10-25
CL2011002781A1 (es) 2012-05-25
IL216004A (en) 2014-01-30
AU2010246114B2 (en) 2012-12-06
BRPI1013748A2 (pt) 2016-04-05
EP2427449B1 (en) 2013-04-03
KR20120004511A (ko) 2012-01-12
MA33244B1 (fr) 2012-05-02
DK2427449T3 (da) 2013-04-22
PE20120812A1 (es) 2012-07-08
US20100286209A1 (en) 2010-11-11
EA201171367A1 (ru) 2012-04-30
AR078411A1 (es) 2011-11-09
TWI382982B (zh) 2013-01-21

Similar Documents

Publication Publication Date Title
MY160390A (en) Vinyl indazolyl compounds
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
AP2960A (en) Substituted pyrimidines for the treatment of diseases such as cancer
SI2358697T1 (sl) Spojine izoindolina za uporabo pri zdravljenju raka
MX2009012228A (es) Compuesto de triazolil aminopirimidina.
PT2340042E (pt) Métodos e composições para o tratamento de cancro
IL214746A0 (en) Substituted pyrimidines for the treatment of cancer
ZA201107879B (en) Composition for the treatment of prostate cancer
MX336022B (es) Activadores de pkm2 bicíclicos.
PL2391363T3 (pl) Kompozycje i sposoby do leczenia raka
PL2605764T3 (pl) Kompozycje do leczenia nowotworu
MX2011011730A (es) Micelas polimericas que contienen sn-38 para el tratamiento de cancer.
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
EP2321012A4 (en) ORGANO-ARSENIC COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
MX2009012233A (es) Compuestos de triazolil aminopirimidina.
ZA201109508B (en) Methods of using corticotropin-releasing factor for the treatment of cancer
EP2411031A4 (en) Methods and compositions for the treatment of cancer
MX2011006532A (es) Compuestos anticancerigenos.
IL209005A0 (en) Use of corticotropin-releasing factor for the treatment of cancer
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
TN2011000545A1 (en) Vinyl indazolyl compounds
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
UA29848U (uk) Застосування системної реконструктивної терапії як способу лікування мігрені
CY1114071T1 (el) Ενωσεις βινυλοϊνδαζολυλιου

Legal Events

Date Code Title Description
FG Grant or registration